Mohty, M <br/><br/>
Thalidomide salvage therapy following allogeneic stem cell transplantation for multiple myeloma: a retrospective study from the Intergroupe Francophone du Myélome (IFM) and the Société Française de Greffe de Moelle et Thérapie Cellulaire (SFGM-TC).  [electronic resource] 

 -  Bone marrow transplantation  Jan 2005 
 - 165-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>0268-3369 
<br/><br/><label>Standard No.: </label>10.1038/sj.bmt.1704756  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Female<br/>Graft vs Host Disease<br/>Hematopoietic Stem Cell Transplantation--methods<br/>Humans<br/>Male<br/>Middle Aged<br/>Multiple Myeloma--mortality<br/>Remission Induction<br/>Retrospective Studies<br/>Salvage Therapy--methods<br/>Survival Analysis<br/>Thalidomide--administration & dosage<br/>Transplantation, Homologous<br/>Treatment Outcome